AmyGo Solutions Receives Second SBIR Award from the NIH

AmyGo Solutions is proud to announce the receipt of our second SBIR award through the National Institutes of Health. This Phase I grant will support the continued development of our proprietary blood test for transthyretin amyloidosis, a fatal and underdiagnosed disease that damages the heart and nerves, affecting hundreds of thousands of Americans.

This award would not have been possible without the incredible support of Alyssa Becker, PhD, and Eva Garland Consulting, LLC, who helped us put together a compelling grant package. We're also deeply grateful for the generous support of LH Capital, Inc. and Lyda Hill Philanthropies, which made this work possible.

We're thrilled to highlight a key collaboration with Natalie Bell, PhD, and Dr. Mark Shen at the University of North Carolina at Chapel Hill, whose contributions will be instrumental in advancing this work.

We remain grateful to our collaborators, partners, and the patients who are waiting for better diagnostic tools for transthyretin amyloidosis. We look forward to sharing updates as we advance toward our next major milestones. Read the original post on LinkedIn →